1
ALL1
Kyowa Pharmaceutical IndustryYear
1
ALL1
2021DEALS // DEV.
1
ALL1
DealsCountry
1
ALL1
JAPAN1
ALL1
Bora PharmaceuticalsTherapeutic Area
1
ALL1
TechnologyStudy Phase
1
ALL1
UndisclosedDeal Type
1
ALL1
PartnershipProduct Type
1
ALL1
UndisclosedDosage Form
1
ALL1
OralLead Product
1
ALL1
UndisclosedTarget
1
ALL1
UndisclosedLead Product(s) : Undisclosed
Therapeutic Area : Technology
Study Phase : Undisclosed
Sponsor : Bora Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Partnership
Details : Upon PMDA’s approval, Bora will be the commercial manufacturing site for the generic product production. Bora Pharmaceuticals’ sites already have an excellent track record with many regulatory agencies around the world.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
May 08, 2021
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Undisclosed
Sponsor : Bora Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Partnership